Age-Related Macular Degeneration (ARMD) Completed Phase 1 Trials for Volociximab (DB06647)

Also known as: Age-related macular degeneration / Macular Degeneration / Senile macular degeneration / Macular degeneration senile / Macular degeneration (senile) of retina, unspecified

DBCOND0034150 (Age-Related Macular Degeneration (ARMD))Completed1 IdentifierTitlePurposeDrugs
NCT00782093A Phase 1 Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular DegenerationTreatment